Results 11 to 20 of about 53,728 (284)

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Vascular malformations in hereditary hemorrhagic telangiectasia (HHT) lead to chronic recurrent bleeding, hemorrhage, stroke, heart failure, and liver disease.
K. Thompson   +6 more
semanticscholar   +1 more source

Teacher’s awareness regarding epistaxis first-aid management inside schools in Asser Region, Saudi Arabia

open access: yesThe Egyptian Journal of Otolaryngology, 2022
Epistaxis is defined as bleeding that originates from the nasal cavity. Considered as one of the most common ENT emergencies, epistaxis is estimated to account for 0.5% of all emergency department visits and up to one-third of all otolaryngology-related ...
Ahmed Saeed Y. Alasiri   +6 more
semanticscholar   +1 more source

Risk Factors and Management for Epistaxis in a Hospitalized Adult Sample

open access: yesSpartan Medical Research Journal, 2022
INTRODUCTION Epistaxis is a common otolaryngologic problem that affects most of the general population. Common risk factors for epistaxis include nasal irritants, nasal/facial oxygen use, certain systemic conditions (e.g., hypertension and coagulopathies)
Andrew Ross   +3 more
semanticscholar   +1 more source

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

open access: yesHepatology, EarlyView., 2022
Hepatic endothelial Alk1 signaling protects from development of vascular malformations while maintaining organ‐specific endothelial differentiation and angiocrine portmanteau of the names Wingless and Int‐1 signaling. Abstract Background and Aims In hereditary hemorrhagic telangiectasia (HHT), severe liver vascular malformations are associated with ...
Christian David Schmid   +20 more
wiley   +1 more source

The Impact of Traditional Anticoagulants, Novel Anticoagulants, and Antiplatelets on Epistaxis

open access: yesThe Laryngoscope, 2021
Anticoagulant and antiplatelet medications (ACAP) are known to be associated with an increased risk for epistaxis. There are conflicting results regarding the impact of Novel Oral Anticoagulants (NOAC) on epistaxis and its severity.
D. Yaniv   +4 more
semanticscholar   +1 more source

Epistaxis first-aid management: a needs assessment among healthcare providers

open access: yesJournal of Otolaryngology - Head & Neck Surgery, 2021
Purpose To perform a needs assessment of epistaxis first-aid measures practiced by family physicians and Emergency Department (ED) staff in London, Ontario, Canada.
L. Sowerby   +3 more
semanticscholar   +1 more source

Study of risk factors and treatment methods in patients presenting with epistaxis to a tertiary care hospital in North Karnataka [PDF]

open access: yesAl Ameen Journal of Medical Sciences, 2023
Background: Epistaxis is a common otorhinolaryngological condition. It is often self-limiting, and only 6-10% of individuals seek medical care. Epistaxis is common in children and elderly.
Kranti Gouripur   +2 more
doaj  

Effects of adenoid and nasal pathologies in pediatric epistaxis

open access: yesActa Medica Alanya, 2022
Aim: The aim of this study was to investigate the effects of adenoid and nasal pathologies in paediatric patients with recurrent epistaxis.Methods: A total of 100 (61 boys, 39 girls) individuals aged 2–17 years (mean age: 8.9 ± 3.6 years) were included ...
Oğuzhan Dikici, Osman Durgut
doaj   +1 more source

Particulate Matter 10 (PM10) Is Associated with Epistaxis in Children and Adults

open access: yesInternational Journal of Environmental Research and Public Health, 2021
The impact of atmospheric concentration of particulate matter ≤10 μm in diameter (PM10) continues to attract research attention. This study aimed to evaluate the effects of meteorological factors, including PM10 concentration, on epistaxis presentation ...
K. Kim, Il-Youp Kwak, H. Min
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy